
Novo Nordisk and Hims End Their Ozempic War. Here’s What It Means for You
Published on March 9, 2026
The companies' new partnership could signal the beginning of the end for compounded GLP-1s.

The companies' new partnership could signal the beginning of the end for compounded GLP-1s.